It is targetting total income of GBP30 billion by 2026, with operating expenses around GBP17 billion. Chief Executive CS Venkatakrishnan said: "We continue to be focused on disciplined execution of ...
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of ...
We think Hexcel is in strong financial health. Unlike many peer suppliers, Hexcel did not need to take out material debt to survive the covid pandemic. Hexcel finished 2023 with a gross debt/EBITDA of ...